Investigation of functionalised nanoplatforms using branched-ligands with different chain lengths for glioblastoma targeting

References

• Watkins S, Sontheimer H. Unique biology of gliomas: challenges and opportunities. Trends Neurosci. 2012;35(9):546–556.
   PubMed Web of Science ®Google Scholar
• Pereira MSL, Klamt F, Thomé CC, et al. Metabotropic glutamate receptors as a new therapeutic target for malignant gliomas. Oncotarget. 2017;8(13):22279–22298.
   PubMedGoogle Scholar
• Ghotme KA, Barreto GE, Echeverria V, et al. Gliomas: new perspectives in diagnosis, treatment and prognosis. Curr Top Med Chem. 2017;17(12):1438–1447.
   PubMed Web of Science ®Google Scholar
• Oberoi RK, Parrish KE, Sio TT, et al. Strategies to improve delivery of anticancer drugs across the blood-brain barrier to treat glioblastoma. Neuro Oncol. 2016;18(1):27–36.
   PubMed Web of Science ®Google Scholar
• Koo YE, Reddy GR, Bhojani M, et al. Brain cancer diagnosis and therapy with nanoplatforms. Adv Drug Deliv Rev. 2006;58(14):1556–1577.
   PubMed Web of Science ®Google Scholar
• Yan H, Wang J, Yi P, et al. Imaging brain tumor by dendrimer-based optical/paramagnetic nanoprobe across the blood-brain barrier. Chem Commun. 2011;47(28):8130–8132.
   PubMed Web of Science ®Google Scholar
• Davies E, Clarke C, Hopkins A. Malignant cerebral glioma–I: survival, disability, and morbidity after radiotherapy. BMJ. 1996;313(7071):1507–1512.
   PubMedGoogle Scholar
• Armstrong CL, Hunter JV, Ledakis GE, et al. Late cognitive and radiographic changes related to radiotherapy: initial prospective findings. Neurology. 2002;59(1):40–48. (b) Gao H, Qian J, Cao S, et al. Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles. Biomaterials. 2012;33(20):5115–5123.
   PubMed Web of Science ®Google Scholar
• Xie JB, Shen ZY, Anraku Y, et al. Nanomaterial-based blood-brain-barrier (BBB) crossing strategies. Biomaterials. 2019;224:119491.
   PubMed Web of Science ®Google Scholar
• Pattni BS, Chupin VV, Torchilin VP. New developments in liposomal drug delivery. Chem Rev. 2015;115(19):10938–10966.
   PubMed Web of Science ®Google Scholar
• Bhujbal SV, De Vos P, Niclou SP. Drug and cell encapsulation: alternative delivery options for the treatment of malignant brain tumors. Adv Drug Deliv Rev. 2014;67–68:142–153.
   PubMed Web of Science ®Google Scholar
• Allen TM, Cullis PR. Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev. 2013;65(1):36–48.
   PubMed Web of Science ®Google Scholar
• Gao H. Progress and perspectives on targeting nanoparticles for brain drug delivery. Acta Pharm Sin B. 2016;6(4):268–286.
   PubMed Web of Science ®Google Scholar
• Gao H. Perspectives on dual targeting delivery systems for brain tumors. J Neuroimmune Pharmacol. 2017;12(1):6–16.
   PubMed Web of Science ®Google Scholar
• Qin L, Wang CZ, Fan HJ, et al. A dual-targeting liposome conjugated with transferrin and arginine-glycine-aspartic acid peptide for glioma-targeting therapy. Oncol Lett. 2014;8(5):2000–2006.
   PubMed Web of Science ®Google Scholar
• Tsuji A, Tamai II. Carrier-mediated or specialized transport of drugs across the blood-brain barrier. Adv Drug Deliv Rev. 1999;36(2–3):277–290.
   PubMed Web of Science ®Google Scholar
• Mikitsh JL, Chacko AM. Pathways for small molecule delivery to the central nervous system across the blood-brain barrier. Perspect Medicin Chem. 2014;6:PMC.S13384–24.
   Google Scholar
• Bhowmik A, Khan R, Ghosh MK. Blood brain barrier: a challenge for effectual therapy of brain tumors. Biomed Res Int. 2015;2015:320941–320960.
   PubMed Web of Science ®Google Scholar
• Yang J, Shi ZY, Liu RY, et al. Combined-therapeutic strategies synergistically potentiate glioblastoma multiforme treatment via nanotechnology. Theranostics. 2020;10(7):3223–3239.
   PubMed Web of Science ®Google Scholar
• Zheng PP, Romme E, Van Der Spek PJ, et al. Glut1/SLC2A1 is crucial for the development of the blood-brain barrier in vivo. Ann Neurol. 2010;68(6):835–844.
   PubMed Web of Science ®Google Scholar
• Spector R. Nutrient transport systems in brain: 40 years of progress. J Neurochem. 2009;111(2):315–320.
   PubMed Web of Science ®Google Scholar
• Peng Y, Zhao Y, Chen Y, et al. Dual-targeting for brain-specific liposomes drug delivery system: synthesis and preliminary evaluation. Bioorg Med Chem. 2018;26(16):4677–4686.
   PubMed Web of Science ®Google Scholar
• Wang J, Ye C, Chen C, et al. Glucose transporter GLUT1 expression and clinical outcome in solid tumors: a systematic review and meta-analysis. Oncotarget. 2017;8(10):16875–16886.
   PubMedGoogle Scholar
• Jiang X, Xin H, Ren Q, et al. Nanoparticles of 2-deoxy-D-glucose functionalized poly(ethylene glycol)-co-poly(trimethylene carbonate) for dual-targeted drug delivery in glioma treatment. Biomaterials. 2014;35(1):518–529.
   PubMed Web of Science ®Google Scholar
• Wang L, Zhang L, Zhao Y, et al. Design, synthesis, and neuroprotective effects of dual-brain targeting naproxen prodrug. Arch Pharm. 2018;351(5):e1700382.
   PubMed Web of Science ®Google Scholar
• Chen Q, Gong T, Liu J, et al. Synthesis, in vitro and in vivo characterization of glycosyl derivatives of ibuprofen as novel prodrugs for brain drug delivery. J Drug Target. 2009;17(4):318–328.
   PubMed Web of Science ®Google Scholar
• Halmos T, Santarromana M, Antonakis K, et al. Synthesis of glucose-chlorambucil derivatives and their recognition by the human GLUT1 glucose transporter. Eur J Pharmacol. 1996;318(2–3):477–484.
   PubMed Web of Science ®Google Scholar
• Fu Q, Zhao Y, Yang Z, et al. Liposomes actively recognizing the glucose transporter GLUT1 and integrin αvβ3 for dual-targeting of glioma. Arch Pharm. 2019;352(2):e1800219.
   PubMed Web of Science ®Google Scholar
• Qu BY, Li XC, Guan M, et al. Design, synthesis and biological evaluation of multivalent glucosides with high affinity as ligands for brain targeting liposomes. Eur J Med Chem. 2014;72:110–118.
   PubMed Web of Science ®Google Scholar
• Ren WX, Han J, Uhm S, et al. Recent development of biotin conjugation in biological imaging, sensing, and target delivery. Chem Commun. 2015;51(52):10403–10418.
   PubMed Web of Science ®Google Scholar
• Mcmahon RJ. Biotin in metabolism and molecular biology. Annu Rev Nutr. 2002;22:221–239.
   PubMed Web of Science ®Google Scholar
• Uchida Y, Ito K, Ohtsuki S, et al. Major involvement of Na+-dependent multivitamin transporter (SLC5A6/SMVT) in uptake of biotin and pantothenic acid by human brain capillary endothelial cells. J Neurochem. 2015;134(1):97–112.
   PubMed Web of Science ®Google Scholar
• Veszelka S, Meszaros M, Kiss L, et al. Biotin and glutathione targeting of solid nanoparticles to cross human brain endothelial cells. Curr Pharm Des. 2017;23(28):4198–4205.
   PubMed Web of Science ®Google Scholar
• Lu R, Zhou L, Yue Q, et al. Liposomes modified with double-branched biotin: a novel and effective way to promote breast cancer targeting. Bioorg Med Chem. 2019;27(14):3115–3127.
   PubMed Web of Science ®Google Scholar
• Li X, Qu B, Jin X, et al. Design, synthesis and biological evaluation for docetaxel-loaded brain targeting liposome with "lock-in" function. J Drug Target. 2014;22(3):251–261.
   PubMed Web of Science ®Google Scholar
• Jang B, Park J-Y, Tung C-H, et al. Gold nanorod-photosensitizer complex for near-infrared fluorescence imaging and photodynamic/photothermal therapy in vivo. ACS Nano. 2011;5(2):1086–1094.
   PubMed Web of Science ®Google Scholar
• Stefanick JF, Ashley JD, Kiziltepe T, et al. A systematic analysis of peptide linker length and liposomal polyethylene glycol coating on cellular uptake of peptide-targeted liposomes. ACS Nano. 2013;7(4):2935–2947.
   PubMed Web of Science ®Google Scholar
• Biessen EA, Beuting DM, Roelen HC, et al. Synthesis of cluster galactosides with high affinity for the hepatic asialoglycoprotein receptor. J. Med. Chem. 1995;38(9):1538–1546.
   PubMed Web of Science ®Google Scholar
• Tian T, Zhu YL, Zhou YY, et al. Exosome uptake through clathrin-mediated endocytosis and macropinocytosis and mediating miR-21 delivery. J Biol Chem. 2014;289(32):22258–22267.
   PubMed Web of Science ®Google Scholar
• West MA, Bretscher MS, Watts C. Distinct endocytotic pathways in epidermal growth factor-stimulated human carcinoma A431 cells. J Cell Biol. 1989;109(6):2731–2739.
   PubMed Web of Science ®Google Scholar
• Englander ZK, Wei HJ, Pouliopoulos AN, et al. Focused ultrasound mediated blood-brain barrier opening is safe and feasible in a murine pontine glioma model. Sci Rep. 2021;11(1):6521.
   PubMed Web of Science ®Google Scholar